Diagnostic efficacy of ischemia modified albumin and its correlation with lipid profile, oxidative stress in acute myocardial infarct patients on admission

Asian Pacific Journal of Tropical Disease

Volumn 2, Issue 1, 2012, Pages 62-65

  Behera, Sudeshna ^a   Mangaraj, Manaswini ^a   Mohapatra, Prakash Chandra ^a  

^a SCB Medical College   (India)

Author keywords

Acute coronary syndrome; Acute myocardial infarction; Cardiac troponin T; Ischemia modified albumin; Malondialdehyde

Indexed keywords

CARDIAC TROPONIN T; ISCHEMIA MODIFIED ALBUMIN; LIPID; TROPONIN T; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ELECTROCARDIOGRAM; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; OXIDATIVE STRESS; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 84856846235     PISSN: 22221808     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2222-1808(12)60015-2     Document Type: Article

References (26)

1. Kumar A, Nagtilak S, Sivakanesan R, Gunasekera S Cardiovascular risk factors inelderly normolipidemic acute myocardial infarct patients-a case controlled study from India. Southeast Asian J Trop Med Public Health 2009, 40(3):581-592.
2. Dominguez-Rodriguez A, Abreu-Gonzalez P Myocardial ischemia-reperfusion injury: Possible role of melatonin. World J Cardiol 2010, 2(8):233-236.
3. Pan SM, Tong CY, Lin Q, Yao CL, Zhao J, Deng Z Ischemia-modified albumin measured with ultra-filtration assay in early diagnosis of acute coronary syndrome. World J Emerg Med 2010, 1(1):37-40.
4. McDonnell B, Hearty S, Leonard P, O'Kennedy R Cardiac biomarkers and the case for point-of-care testing. Clin Biochem 2009, 42:549-561.
5. Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC Role of "ischemia modified albumin", a new biochemical marker of myocardial ischemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004, 21:29-34.
6. Wudkowska A, Goch J, Goch A Ischemia-modified albumin in differential diagnosis of acute coronary syndrome without ST elevation and unstable angina pectoris. Kardiol Pol 2010, 68(4):431-437.
7. Sbarouni E, Georgiadou P, Voudris V Ischemia modified albumin changes-review and clinical implications. Clin Chem Lab Med 2011, 49(2):177-184.
8. Wu AB, Morris DL, Fletcher DR, Apple FS, Christenson RH, Painter PC Analysis of the albumin cobalt binding (ACB) test as an adjunct to cardiac troponin I for the early detection of acute myocardial infarction. Cardiovasc Toxicol 2001, 1:147-151.
9. Bhagavan NV, Lai EM, Rios PA, Yang J, Ortega-Lopez AM, Shinoda H, et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 2003, 49:581-585.
10. Bar-Or D, Lau E, Winkler JV A novel assay for cobalt albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 2000, 19:311-315.
11. Satoh K Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 1978, 90:37-43.
12. Sbarouni E, Georgiadou P, Kremastinos D, Voudris V Ischemia modified albumin: is this marker of ischemia ready for prime time use. Hellenic J Cardiol 2008, 49:260-266.
13. Cui LY, Zhang J, Wu YH, Hu XZ Assay of ischemia modified albumin and C-reactive protein for early diagnosis of acute coronary syndrome. J Clin Lab Anal 2008, 22:45-49.
14. Pasupathi P, Rao YY, Farook J, Saravanan G, Bakthavathsalam G Oxidative stress and cardiac biomarkers in patients with acute myocardial infarction. Eur J Sci Res 2009, 27(2):275-285.
15. David C Gaze Ischemia modified albumin: A novel biomarker for the detection of cardiac ischemia. Drug Metab Pharmacokinet 2009, 24(4):333-341.
16. Charpentier S, Ducasse JL, Cournot M, Maupas-Schwalm F, Elbaz M, Baixas C, et al. Clinical assessment of ischemia-modified albumin and heart fatty acid-binding protein in the early diagnosis of non-ST-elevation acute coronary syndrome in the emergency department. Acad Emerg Med 2010, 17(1):27-35.
17. Moe KT, Wong P Current trends in diagnostic biomarkers of acute coronary syndrome. Ann Acad Med Singapore 2010, 39:210-215.
18. Abadie JM, Blassingame CL, Bankson DD Albumin cobalt binding assay to rule out acute coronary syndrome. Ann Clin Lab Sci 2005, 35:66-72.
19. Pantheghini M Cardiac: is this biomarker ready for the prime time?. Scand J Clin Lab Invest 2010, 70(Suppl 242):66-72.
20. Kumar A, Sivakanesan R, Gunasekera S Ischemia modified albumin a potent marker in acute myocardial infarction in normolipidaemic. Pak J Med Sci 2008, 24(3):364-367.
21. Takhshid MA, Kojuri J, Tabei SMB, Tavasouli AR, Heidary S, Tabandeh M Early diagnosis of acute coronary syndrome with sensitive troponin I and ischemia modified albumin. Iran Cardiovasc Res J 2010, 4(4).
22. Christenson RH, Duh SH, Sanhal WR, Wu AHB, Holtman V, Painter P, et al. Characteristics of an albumin cobalt binding test for the assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 2001, 47:464-470.
23. Keating L, Benger JR, Beetham R, Bateman S, Veysey S, Kendall J, et al. The PRIMA study: presentation ischaemia-modified albumin in the emergency department. Emerg Med J 2006, 23(10):764-768.
24. Collinson PO, Gaze DC, Bainbridge K, Morris F, Morris B, Price A, et al. Utility of admission cardiac troponin and "ischemia modified albumin" measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department. Emerg Med J 2006, 23(4):256-261.
25. Senes M, Kazan N, Coskun O, Inan L, Yucel D Oxidative and nitrosative stress in acute ischemic stroke. Ann Clin Biochem 2007, 44(Pt 1):43-47.
26. Kumar A, Sivakanesan R, Gunasekera S Oxidative stress, endogenous antioxidant and ischemia modified albumin in normolipidemic acute myocardial infarction patients. J Health Sci 2008, 54(4):482-487.